Projects per year
Personal profile
Education
- 2016-2020 Ph.D., Graduate Institute of Medical Sciences, Taipei Medical University
- 2002-2009 M.D., School of Medicine, China Medical University
Experience
- Attending Physician, Division of Otolaryngology, Taipei Medical University Hospital
- 2021.01- Director, Division of Otolaryngology, Taipei Medical University Hospital
- 2020.09- Assistant Professor, Department of Otolaryngology-Head & Neck Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2020.04-2020.12 Acting Director, Division of Otolaryngology, Taipei Medical University Hospital
- 2011.07-2016.06 Resident Physician, Division of Otolaryngology, Taipei Medical University Hospital
- 2010.08-2011.06 Resident Physician, Department of Emergency Medicine, National Taiwan University Hospital
Fingerprint
Dive into the research topics where Che-Hsuan Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
開發尼古丁乙醯膽鹼受體亞型5之單鏈變異片段型抗體及評估此一抗體對於增強口腔癌之放射線敏感度的治療效果
8/1/20 → 7/31/21
Project: A - Government Institution › b - Ministry of Science and Technology
Research output
-
DNA polymerase theta repression enhances the docetaxel responsiveness in metastatic castration-resistant prostate cancer
Kuei, C. H., Lin, H. Y., Lin, M. H., Lee, H. H., Lin, C. H., Lee, W. J., Chen, Y. L., Lu, L. S., Zheng, J. Q., Hung, R. C., Chiu, H. W., Chen, K. C. & Lin, Y. F., Dec 1 2020, In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 1866, 12, p. 165954 165954.Research output: Contribution to journal › Article › peer-review
-
Erratum: Histone 2A family member J drives mesenchymal transition and temozolomide resistance in glioblastoma multiforme (Cancers, (2020) 12, 1, 10.3390/cancers12010098)
Lee, H. H., Lin, C. H., Lin, H. Y., Kuei, C. H., Zheng, J. Q., Wang, Y. H., Lu, L. S., Lee, F. P., Hu, C. J., Wu, D. & Lin, Y. F., Sep 2020, In: Cancers. 12, 9, p. 1-3 3 p., 2649.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
FOXD1 Repression Potentiates Radiation Effectiveness by Downregulating G3BP2 Expression and Promoting the Activation of TXNIP-Related Pathways in Oral Cancer
Lin, C-H., Lee, H-H., Chang, W-M., Lee, F-P., Chen, L-C., Lu, L-S. & Lin, Y-F., Sep 21 2020, In: Cancers. 12, 9, p. 1-17 17 p., 2690.Research output: Contribution to journal › Article › peer-review
-
Histone 2A family member j drives mesenchymal transition and temozolomide resistance in glioblastoma multiforme
Lee, H. H., Lin, C. H., Lin, H. Y., Kuei, C. H., Zheng, J. Q., Wang, Y. H., Lu, L. S., Lee, F. P., Hu, C. J., Wu, D. & Lin, Y. F., Jan 2020, In: Cancers. 12, 1, 98.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
IMPA2 Downregulation Enhances mTORC1 Activity and Restrains Autophagy Initiation in Metastatic Clear Cell Renal Cell Carcinoma
Kuei, C-H., Lin, H. Y., Lee, H-H., Lin, C-H., Zheng, J-Q., Chen, K-C. & Lin, Y-F., Mar 30 2020, In: Journal of Clinical Medicine. 9, 4, p. 956Research output: Contribution to journal › Article › peer-review